Your session is about to expire
← Back to Search
Focused Ultrasound
Neuro Ablation - Functional for Epilepsy (EP001 Trial)
N/A
Waitlist Available
Led By Nathan Fountain, MD
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a new brain surgery to treat epilepsy is safe and effective.
Eligible Conditions
- Epilepsy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Exablate Neuro System TreatmentExperimental Treatment1 Intervention
MR-Guided Focused Ultrasound will be used to ablate epileptic foci up to 8 cm3 in size.
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
91 Previous Clinical Trials
3,778 Total Patients Enrolled
1 Trials studying Epilepsy
20 Patients Enrolled for Epilepsy
Food and Drug Administration (FDA)FED
180 Previous Clinical Trials
1,543,894 Total Patients Enrolled
3 Trials studying Epilepsy
72 Patients Enrolled for Epilepsy
Nathan Fountain, MDPrincipal InvestigatorUniversity of Virginia
1 Previous Clinical Trials
240 Total Patients Enrolled
1 Trials studying Epilepsy
240 Patients Enrolled for Epilepsy
Share this study with friends
Copy Link
Messenger